SCNI
Scinai Immunotherapeutics
SCNI
SCNI
4 hedge funds and large institutions have $85.1K invested in Scinai Immunotherapeutics in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$78.6K |
Top Sellers
| 1 |
APC
1
Aspire Private Capital
Cornelius,
North Carolina
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $78.6K | +$78.5K | +23,458 | +78,193% |
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $5.5K | – | – | – |
|
3
Morgan Stanley
New York
| $853 | – | – | – |
|
4
Credit Agricole
Montrouge Cedex,
France
| $140 | – | – | – |
|
|
APC
5
Aspire Private Capital
Cornelius,
North Carolina
| – | -$110 | -32 | Closed |
|